HERG K+ channel expression in CD34+/CD38−/CD123high cells and primary leukemia cells and analysis of its regulation in leukemia cells

被引:0
|
作者
Huiyu Li
Liqiong Liu
Linlin Guo
Jiahua Zhang
Wen Du
Xiaoqing Li
Wei Liu
Xiangjun Chen
Shiang Huang
机构
[1] Institute of Hematology,Center for Stem Cell Research and Application
[2] Union Hospital of Tongji Medical College,undefined
[3] Huazhong University of Science and Technology,undefined
来源
关键词
HERG K; channels; CD34; /CD38; /CD123; cells; Leukemia;
D O I
暂无
中图分类号
学科分类号
摘要
The human ether-a-go-go-related (herg) gene encoding K+ channels (HERG) belongs to an evolutionarily conserved multigene family of voltage activated K+ channels. The functional properties of HERG K+ channels are complex and their contribution to the repolarization of the cardiac action potential are well understood. Recent studies revealed that HERG K+ channels are preferentially expressed in different histogenesis of tumor cells. Leukemia is a cancer that originates in the bone marrow hematopoietic stem cells (HSCs). Leukemia stem cells (LSCs) are critical in the perpetuation of the disease. A better understanding of LSCs and molecular biology will allow the design of more effective therapies. We report in this study that herg was expressed in CD34+/CD38−/CD123high LSCs but not expressed in normal bone marrow CD34+/CD38− HSCs. In addtion, herg is also expressed in leukemia cell lines K562 and HL-60 and almost all the primary leukemia cells whereas not in the normal bone marrow cells. In addition, the expression of herg mRNA was not associated with the clinical and cytogenetic feature of leukemia. Moreover, HERG K+ channels can regulate leukemia cells proliferation and cell cycle. These data provide evidence for the oncogenic potential of HERG K+ channels and it may be a novel, potential pharmacological target for leukemia therapy in the future.
引用
收藏
页码:387 / 392
页数:5
相关论文
共 50 条
  • [21] Human cord blood long-term engrafting cells are CD34+ CD38−
    F Ishikawa
    A G Livingston
    H Minamiguchi
    J R Wingard
    M Ogawa
    Leukemia, 2003, 17 : 960 - 964
  • [22] Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CML
    Herrmann, Harald
    Sadovnik, Irina
    Eisenwort, Gregor
    Ruelicke, Thomas
    Blatt, Katharina
    Herndlhofer, Susanne
    Willmann, Michael
    Stefanzl, Gabriele
    Baumgartner, Sigrid
    Greiner, Georg
    Schulenburg, Axel
    Mueller, Niklas
    Rabitsch, Werner
    Bilban, Martin
    Hoermann, Gregor
    Streube, Berthold
    Vallera, Daniel A.
    Sperr, Wolfgang R.
    Valent, Peter
    BLOOD ADVANCES, 2020, 4 (20) : 5118 - 5132
  • [23] CD34+CD38-CD58- cells are leukemia-propagating cells in Philadelphia chromosome-positive acute lymphoblastic leukemia
    Kong, Y.
    Chang, Y-J
    Liu, Y-R
    Wang, Y-Z
    Jiang, Q.
    Jiang, H.
    Qin, Y-Z
    Hu, Y.
    Lai, Y-Y
    Duan, C-W
    Hong, D-L
    Huang, X-J
    LEUKEMIA, 2014, 28 (12) : 2398 - 2401
  • [24] Immunoprofiling of leukemic stem cells CD34+/CD38−/CD123+ delineate FLT3/ITD-positive clones
    Adhra Al-Mawali
    David Gillis
    Ian Lewis
    Journal of Hematology & Oncology, 9
  • [25] Isolation of CD34- and CD34+ Leukemia Stem Cells from Acute Myeloid Leukemia Blasts Using CD200
    Ho, Jenny M.
    Dobson, Stephanie M.
    McLeod, Jessica
    Voisin, Veronique
    Murison, Alex
    Kennedy, James
    Zandi, Sasan
    Eppert, Kolja
    Minden, Mark D.
    Lupien, Mathieu
    Dick, John E.
    Wang, Jean C. Y.
    BLOOD, 2018, 132
  • [26] Functional expression of Fas (CD95) in acute myeloid leukemia cells in the context of CD34 and CD38 expression: Possible correlation with sensitivity to chemotherapy
    Iijima, N
    Miyamura, K
    Itou, T
    Tanimoto, M
    Sobue, R
    Saito, H
    BLOOD, 1997, 90 (12) : 4901 - 4909
  • [27] Genetic modification of primary chronic lymphocytic leukemia cells with a lentivirus expressing CD38
    Pearce, Laurence
    Morgan, Liam
    Lin, Thet Thet
    Hewamana, Saman
    Matthews, R. James
    Deaglio, Silvia
    Rowntree, Clare
    Fegan, Christopher
    Pepper, Christopher
    Brennan, Paul
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (03): : 514 - 517
  • [28] SIDE POPULATION AND CD34+, CD38 (NEG/DIM) IMMUNOPHENOTYPE SHOW DISCORDANT EXPRESSION IN ACUTE MYELOID LEUKEMIA
    Roshal, Mikhail
    Becker, Pamela
    Chien, Sylvia
    Wood, Brent
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2009, 76B (06) : 403 - 403
  • [29] The prognostic effect on childhood acute lymphoblastic leukemia of CD34+CD38- expressed in leukemia cells
    Zhao, Jiou
    Wang, Yun
    Zhou, Min
    Gao, Jizhao
    Yuan, Yufang
    HEMATOLOGY, 2022, 27 (01) : 706 - 713
  • [30] Assessment of the normal or leukemic nature of CD34+ cells in acute myeloid leukemia with low percentages of CD34 cells
    Van Der Pol, MA
    Feller, N
    Roseboom, M
    Moshaver, B
    Westra, G
    Broxterman, HJ
    Ossenkoppele, GJ
    Schuurhuis, GJ
    HAEMATOLOGICA, 2003, 88 (09) : 983 - 993